Wall Street analysts expect Alcentra Capital Corp. (NASDAQ:ABDC) to post sales of $8.91 million for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Alcentra Capital Corp.’s earnings. The highest sales estimate is $9.35 million and the lowest is $8.40 million. Alcentra Capital Corp. reported sales of $9.12 million in the same quarter last year, which would suggest a negative year over year growth rate of 2.3%. The company is scheduled to report its next earnings results on Thursday, November 2nd.

On average, analysts expect that Alcentra Capital Corp. will report full-year sales of $8.91 million for the current year, with estimates ranging from $34.95 million to $37.19 million. For the next financial year, analysts anticipate that the firm will report sales of $38.87 million per share, with estimates ranging from $36.58 million to $40.12 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Alcentra Capital Corp..

Several research firms recently commented on ABDC. Raymond James Financial, Inc. lowered Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from $16.00 to $14.00 in a research report on Monday, July 17th. ValuEngine lowered Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Keefe, Bruyette & Woods set a $14.00 price target on Alcentra Capital Corp. and gave the stock a “hold” rating in a research report on Wednesday, May 31st. TheStreet lowered Alcentra Capital Corp. from a “b” rating to a “c+” rating in a research report on Monday, July 24th. Finally, DA Davidson began coverage on Alcentra Capital Corp. in a research report on Wednesday, July 5th. They issued a “buy” rating and a $15.00 price target for the company. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Alcentra Capital Corp. presently has a consensus rating of “Hold” and an average price target of $13.50.

Shares of Alcentra Capital Corp. (NASDAQ ABDC) opened at 10.94 on Monday. The stock’s 50 day moving average price is $10.88 and its 200-day moving average price is $12.84. Alcentra Capital Corp. has a 52 week low of $10.20 and a 52 week high of $14.73.

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 5th. Investors of record on Saturday, September 30th will be given a $0.34 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.36 annualized dividend and a yield of 12.43%. Alcentra Capital Corp.’s dividend payout ratio is currently -1,700.00%.

TRADEMARK VIOLATION WARNING: “$8.91 Million in Sales Expected for Alcentra Capital Corp. (ABDC) This Quarter” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/18/8-91-million-in-sales-expected-for-alcentra-capital-corp-abdc-this-quarter.html.

In other Alcentra Capital Corp. news, Director Steven H. Reiff bought 11,668 shares of the company’s stock in a transaction on Monday, August 7th. The stock was acquired at an average price of $10.72 per share, for a total transaction of $125,080.96. Following the completion of the transaction, the director now directly owns 7,000 shares of the company’s stock, valued at $75,040. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 4.96% of the company’s stock.

Several large investors have recently made changes to their positions in ABDC. Muzinich & Co. Inc. boosted its position in shares of Alcentra Capital Corp. by 98.3% during the first quarter. Muzinich & Co. Inc. now owns 452,913 shares of the asset manager’s stock valued at $6,223,000 after buying an additional 224,537 shares during the period. Raymond James Financial Services Advisors Inc. boosted its position in shares of Alcentra Capital Corp. by 93.4% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 166,750 shares of the asset manager’s stock valued at $2,291,000 after buying an additional 80,544 shares during the period. Salem Investment Counselors Inc. purchased a new position in shares of Alcentra Capital Corp. during the second quarter valued at approximately $646,000. UBS Group AG boosted its position in shares of Alcentra Capital Corp. by 20.7% during the first quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock valued at $3,558,000 after buying an additional 44,387 shares during the period. Finally, Mackenzie Financial Corp purchased a new position in shares of Alcentra Capital Corp. during the first quarter valued at approximately $491,000. Institutional investors and hedge funds own 31.49% of the company’s stock.

About Alcentra Capital Corp.

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Get a free copy of the Zacks research report on Alcentra Capital Corp. (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Stock Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related stocks with our FREE daily email newsletter.